Insulin resistance in polycystic ovary syndrome

被引:5
|
作者
Schröder, AK
Tauchert, S
Ortmann, O
Diedrich, K
Weiss, JM
机构
[1] Univ Klinikum Schleswig Hostein, Klin Frauenheilkunde & Geburtshilfe, D-23538 Lubeck, Germany
[2] Univ Klinikum Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
关键词
polycystic ovary syndrome; PCOS; insulin resistance; diabetes mellitus; cardiovascular risk; risks;
D O I
10.1007/BF03041041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With a prevalence of 5-10% the polycystic ovary syndrome (PCOS) is a common disorder of premenopausal women. According to prospective studies abnormal glucose tolerance and diabetes mellitus present in about 10.0% and 35.0% of adult women with PCOS, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension and dyslipidaemia. The rate of spontaneous abortions as well as the risk of developing gestational diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem, but a complex endocrine disease with important health implications. The role of glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.
引用
收藏
页码:812 / 821
页数:10
相关论文
共 50 条
  • [21] The role of insulin resistance in polycystic ovary syndrome
    Legro, RS
    Dunaif, A
    [J]. ENDOCRINOLOGIST, 1996, 6 (04): : 307 - 321
  • [22] Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome
    Hong, So-hyeon
    Sung, Yeon-Ah
    Hong, Young Sun
    Jeong, Kyungah
    Chung, Hyewon
    Lee, Hyejin
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 87 (04) : 375 - 380
  • [23] Markers of insulin resistance and metabolic syndrome in polycystic ovary
    Trimeche, S.
    Safer, M. Abid
    Chaieb, M. Chadli
    Ajina, M. Zaouali
    Elghezal, R. Braham
    Beizig, A. Maaroufi
    Ach, K.
    Njah, M. Kacem
    Chaieb, L.
    [J]. DIABETES & METABOLISM, 2011, 37 : A70 - A70
  • [24] Limitations of insulin resistance assessment in polycystic ovary syndrome
    Lewandowski, Krzysztof C.
    Plusajska, Justyna
    Horzelski, Wojciech
    Bieniek, Ewa
    Lewinski, Andrzej
    [J]. ENDOCRINE CONNECTIONS, 2018, 7 (03): : 403 - 412
  • [25] Current perspectives of insulin resistance and polycystic ovary syndrome
    Pauli, J. M.
    Raja-Khan, N.
    Wu, X.
    Legro, R. S.
    [J]. DIABETIC MEDICINE, 2011, 28 (12) : 1445 - 1454
  • [26] Obesity and insulin resistance in women with polycystic ovary syndrome
    Hsu Chun-Sen
    Wu Chien-Hua
    Chiu Wan-Chun
    Lee Ching-Tzu
    Chang Chun-Jen
    Hsu Ming-, I
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (05) : 300 - 306
  • [27] New markers of insulin resistance in polycystic ovary syndrome
    Polak, K.
    Czyzyk, A.
    Simoncini, T.
    Meczekalski, B.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (01): : 1 - 8
  • [28] Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
    Shang, Yujie
    Zhou, Huifang
    Hu, Minghui
    Feng, Hua
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10): : 1 - 15
  • [29] Rosiglitazone improves insulin resistance in polycystic ovary syndrome
    Rebecca Ireland
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2005, 1 (1): : 7 - 8
  • [30] The role of miRNAs in polycystic ovary syndrome with insulin resistance
    Luo, Yingliu
    Cui, Chenchen
    Han, Xiao
    Wang, Qian
    Zhang, Cuilian
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (02) : 289 - 304